COMET stands for Comparing an Operation to Monitoring, with or without Endocrine Therapy, for low-risk DCIS.
The COMET Study is being conducted across the United States to compare two treatment approaches for low-risk DCIS: Active Monitoring and Surgery.
The COMET study is needed because these treatment approaches have not been compared directly before in patients with low-risk DCIS.
COMET is the first large phase III randomized clinical trial in the United States (US) to look at different management strategies for low-risk DCIS. The COMET Study will enroll 1200 women with low-risk DCIS at about 100 sites throughout the US. The study is funded by the Patient-Centered Outcomes Research Institute (PCORI).
Shelley Hwang
Principal Investigator
Ann Partridge
Co-Principal Investigator
Alastair Thompson
Co-Principal Investigator
Elizabeth Frank
Lead Patient Advocate
Deborah Collyar
Patient Advocate
Donna Pinto
Patient Advocate
Desiree Basila
Patient Advocate
Terry Hyslop
Statistician
Thomas Lynch
Project Manager
